Antibody-mediated Rejection: Clinical Trials

3 trials for Antibody-mediated Rejection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Antibody-mediated Rejection: new trials by email Literature Review of Antibody-mediated Rejection trials Research Report on Antibody-mediated Rejection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Desensitization in Kidney Allograft Using Daratumumab
Daratumumab dose escalation, Daratumumab full dose - Allosensitization, Kidney Transplant Rejection
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris212020-02-182024-03-19
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Clazakizumab - Kidney Failure, Chronic, End-Stage Renal Disease
Phase 1 / Phase 2CompletedStanley Jordan, MD202018-02-272026-10-30
Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant
Clazakizumab - Antibody-mediated Rejection, Kidney Transplant; Complications
Phase 1 / Phase 2CompletedStanley Jordan, MD102018-02-212025-05-06

Narrower conditions

Kidney Failure, Chronic (1)  ·  Rejection, Psychology (1)

Broader conditions

Behavior (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Social Behavior (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

clazakizumab (2)

Sponsors

Stanley Jordan, MD (2)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (2)  ·  France (1)

Top investigators

Stanley Jordan, MD (2)  ·  Marie Matignon, MD (1)

Results publications

PMID 37322595, PMID 39134120